Quantitation of Glymphatic Functioning in Sleep and Meditative States
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · Aug 6, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how sleep and meditation affect a system in our brains called the glymphatic system, which helps clear waste and maintain brain health. Researchers are using advanced MRI techniques to study these effects in healthy volunteers who are experienced meditators. The goal is to learn more about how these practices could potentially benefit people with Parkinson's disease and improve their sleep quality.
To participate in the trial, you need to be between 14 and 45 years old and have a good amount of meditation experience. Unfortunately, if you have certain medical implants, feel anxious in small spaces, or have recently had an infection or injury, you may not be eligible. Participants will undergo MRI scans, so they should be comfortable lying still for a while. It's important to avoid stimulants and alcohol before your visit. This study is currently looking for volunteers, and it could be a great opportunity to contribute to important research on brain health and meditation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ages 14-45
- • "Adept meditator status"
- Exclusion Criteria:
- • Any non-MR compatible material implant, or contraindication to MR scanning
- • Claustrophobia or inability to lie still for prolonged periods of time
- • Participants with a recent (less than 2 months) infection, tattoo, or wound
- • No consumption of stimulants or alcohol within 12 hours of the study visit
- • clinical diagnosis of any major neurological or psychological condition
- • Taking benzodiazepines, cholinestorase inhibitors, anti-psychotics, opioids, MAO inhibitors
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Patients applied
Trial Officials
Daniel Claassen, MD
Principal Investigator
Vanderbilt University Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials